![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 237/32 | |
C07D 403/06 | |||
C07D 403/04 | |||
C07D 403/14 | |||
A61K 31/502 | |||
A61P 29/00 | |||
A61P 37/08 |
(11) | Number of the document | 2007735 |
(13) | Kind of document | T |
(96) | European patent application number | 07728235.8 |
Date of filing the European patent application | 2007-04-18 | |
(97) | Date of publication of the European application | 2008-12-31 |
(45) | Date of publication and mention of the grant of the patent | 2010-10-27 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2007/053773 |
Date | 2007-04-18 |
(87) | Number | WO 2007/122156 |
Date | 2007-11-01 |
(30) | Number | Date | Country code |
0607839 | 2006-04-20 | GB | |
0706160 | 2007-03-29 | GB | |
0706176 | 2007-03-29 | GB |
(72) |
GORE, Paul, Martin, GB
HANCOCK, Ashley, Paul, GB
HODGSON, Simon, Teanby, GB
KINDON, Leanda, Jane, GB
PROCOPIOU, Panayiotis, Alexandrou, GB
|
(73) |
Glaxo Group Limited,
Glaxo Wellcome House Berkeley Avenue, Greenford Middlesex UB6 0NN,
GB
|
(54) | 2-SUBSTITUTED 4-BENZYLPHTHALAZINONE DERIVATIVES AS HISTAMINE H1 AND H3 ANTAGONISTS |
2-SUBSTITUTED 4-BENZYLPHTHALAZINONE DERIVATIVES AS HISTAMINE H1 AND H3 ANTAGONISTS |